UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave Aurora, CO 80045Phone: 720-848-0000
Hematology
Board Certified
I believe in finding the best, most cutting edge treatments to personalize care for my patients
Optimal management of leukemias and their complications
Clinical Director of Leukemia Services
Doctor of Medicine Master of Science
Hematology, Internal Medicine, Medical Oncology
720-848-6400
Male
English
University of Colorado Hospital
Phone: 720-848-0000
Lymphoma , Leukemia (Adult Acute) , Leukemia (Adult Chronic)
Blood Disorders
Personal Interests
Dr. Pollyea received his MD degree from the University of Chicago Pritzker School of Medicine. He stayed at the University of Chicago Hospital for his residency in Internal Medicine and served as Chief Medical Resident at Cook County Hospital. He then completed his fellowship training in Hematology and Oncology at Stanford University, where he also completed a Masters degree in Epidemiology with an emphasis on biostatistics and clinical trial design. In 2011 he came to the University of Colorado where he is currently the Clinical Director of Leukemia Services. Dr. Pollyea has served as the Principal Investigator of multiple early-phase clinical trials, and has received funding for his work from the American Society of Hematology, the American Society of Clinical Oncology and the Leukemia and Lymphoma Society. He has over 80 peer-reviewed publications and has spoken at many national and international meetings.
Professor, Medicine-Hematology
American Society of Clinical Oncology, Member American Society of Hematology, Member Leukemia and Lymphoma Society, Rocky Mountain Region, Board of Directors National Comprehensive Cancer Network, Panelist (acute myeloid leukemia, myelodysplastic syndromes)
Grants
Special Fellow in Clinical Research (2010)
Scholar in Clinical Research (2019)
Research Interests for Patients
Dr. Pollyea’s research interests involve developmental therapeutics for myeloid malignancies (myelodysplastic syndromes and acute myeloid leukemia) through collaborative laboratory-based efforts and clinical trials involving novel therapies that he designs and leads. He is interested in developing drugs that target leukemia cells that will allow for definitive and curative therapies.
MD, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (2003)
BS, Indiana University–Bloomington (IN) (1999)
MS, Stanford University (2011)
University of Chicago Program (2006)
John H Stroger Hospital of Cook County Program (2007)
Stanford University Program (2010)
720-848-6400